Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Riederer

Showing results (21-30 of 587) with videos related to

Pageof 59
Sort By:
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in manM Gerlach, P Riederer
Journal of Neural Transmission|January 1, 1975
Biochemical post-mortem findings in depressed patientsW Birkmayer, P Riederer
Journal of Neural Transmission|January 1, 1977
Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem materialK Jellinger, P Riederer
Journal of Neural Transmission|January 1, 1976
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysisP Riederer, S Wuketich
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1987
Biochemical and morphological changes in the aging brainP Riederer, P Kruzik
Journal of Neural Transmission (Vienna, Austria : 1996)|November 25, 2003
Selegiline's neuroprotective capacity revisitedP Riederer, L Lachenmayer
Pharmacopsychiatry|November 1, 1992
Therapeutic drug monitoring of psychotropics: report of a consensus conferenceP Riederer, G Laux
Advances in Neurology|January 1, 1984
Deprenyl prolongs the therapeutic efficacy of combined L-DOPA in Parkinson's diseaseW Birkmayer, P Riederer
Advances in Neurology|January 1, 1984
Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activityK Jellinger, P Riederer
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)P Riederer, K Jellinger
Pageof 59

Showing results (21-30 of 587) with videos related to

Sort By:
Pageof 59
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in manM Gerlach, P Riederer
Journal of Neural Transmission|January 1, 1975
Biochemical post-mortem findings in depressed patientsW Birkmayer, P Riederer
Journal of Neural Transmission|January 1, 1977
Brain monoamines in metabolic (endotoxic) coma. A preliminary biochemical study in human postmortem materialK Jellinger, P Riederer
Journal of Neural Transmission|January 1, 1976
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysisP Riederer, S Wuketich
Electroencephalography and Clinical Neurophysiology. Supplement|January 1, 1987
Biochemical and morphological changes in the aging brainP Riederer, P Kruzik
Journal of Neural Transmission (Vienna, Austria : 1996)|November 25, 2003
Selegiline's neuroprotective capacity revisitedP Riederer, L Lachenmayer
Pharmacopsychiatry|November 1, 1992
Therapeutic drug monitoring of psychotropics: report of a consensus conferenceP Riederer, G Laux
Advances in Neurology|January 1, 1984
Deprenyl prolongs the therapeutic efficacy of combined L-DOPA in Parkinson's diseaseW Birkmayer, P Riederer
Advances in Neurology|January 1, 1984
Dementia in Parkinson's disease and (pre) senile dementia of Alzheimer type: morphological aspects and changes in the intracerebral MAO activityK Jellinger, P Riederer
Acta Neurologica Scandinavica. Supplementum|January 1, 1983
Neurochemical insights into monoamine oxidase inhibitors, with special reference to deprenyl (selegiline)P Riederer, K Jellinger
Pageof 59